[Genetic markers in benign hypertrophy of the prostate].
The distribution of phenotypes and gene frequencies of the C3 component of complement, group-specific component, transferrin and haptoglobin were studied in 155 patients with benign prostatic hyperplasia. A statistical analysis of the findings in comparison with the frequency of these genes in the general population failed to demonstrate any correlation between phenotype distribution and benign prostatic hyperplasia.
D003176:Complement C3 / Q000235:genetics*; D005787:Gene Frequency; D005819:Genetic Markers; D006115:Greece; D006242:Haptoglobins / Q000235:genetics; D006801:Humans; D008297:Male; D010641:Phenotype; D011470:Prostatic Hyperplasia / Q000235:genetics*; D012712:Serum Globulins / Q000235:genetics*; D014168:Transferrin / Q000235:genetics
D003176:Complement C3; D005819:Genetic Markers; D006242:Haptoglobins; D012712:Serum Globulins; D014168:Transferrin
Marqueurs génétiques dans l'hypertrophie bénigne de la prostate.